Publications by authors named "Guido Marcucci"

100Publications

Exosomes-driven lipolysis and bone marrow niche remodeling supports leukemia expansion.

Haematologica 2020 Sep 10;Online ahead of print. Epub 2020 Sep 10.

Department of Radiation Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA..

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.246058DOI Listing
September 2020

Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia.

Biol Blood Marrow Transplant 2020 Dec 29;26(12):e322-e327. Epub 2020 Aug 29.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.08.027DOI Listing
December 2020

Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy.

Leuk Lymphoma 2020 Aug 19:1-2. Epub 2020 Aug 19.

Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1808213DOI Listing
August 2020

HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML.

Aging (Albany NY) 2020 Jul 29;12(17):16759-16774. Epub 2020 Jul 29.

Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/aging.103605DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521497PMC
July 2020

Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.

Am J Hematol 2020 Jul 6. Epub 2020 Jul 6.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Gehr Family Center for Leukemia Research, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25929DOI Listing
July 2020

Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.

Cancer Cell 2020 Jul 11;38(1):79-96.e11. Epub 2020 Jun 11.

Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA 91016, USA; City of Hope Comprehensive Cancer Center and Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2020.04.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363590PMC
July 2020

Discovery of proangiogenic CD44+mesenchymal cancer stem cells in an acute myeloid leukemia patient's bone marrow.

J Hematol Oncol 2020 06 3;13(1):63. Epub 2020 Jun 3.

Division of Hematology and Oncology, Loma Linda University Medical Center, Loma Linda, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-020-00899-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268388PMC
June 2020

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2020 Aug 19;26(8):1425-1432. Epub 2020 May 19.

Department of Hematology and HCT, City of Hope, Duarte, California; Department of Computational Quantitative Medicine/BRI, City of Hope, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.04.015DOI Listing
August 2020

State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Development of Acute Myeloid Leukemia.

Cancer Res 2020 Aug 15;80(15):3157-3169. Epub 2020 May 15.

Department of Hematological Malignancies Translational Science, Hematology & Hematopoietic Cell Transplantation and the Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-20-0354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416495PMC
August 2020

The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement.

Leuk Lymphoma 2020 08 19;61(8):2020-2023. Epub 2020 Mar 19.

Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1742908DOI Listing
August 2020

Requirement of GTP binding for TIF-90-regulated ribosomal RNA synthesis and oncogenic activities in human colon cancer cells.

J Cell Physiol 2020 Oct 11;235(10):7567-7579. Epub 2020 Mar 11.

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.29661DOI Listing
October 2020

Phase I study of AR-42 and decitabine in acute myeloid leukemia.

Leuk Lymphoma 2020 06 8;61(6):1484-1492. Epub 2020 Feb 8.

Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1719095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375689PMC
June 2020

Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.

Nat Commun 2019 11 7;10(1):5051. Epub 2019 Nov 7.

Department of Hematology-Oncology, International Cancer Center, Shenzhen University General Hospital, Shenzhen University Health Science Center, 1098 Xueyuan Ave, 518060, Shenzhen, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-12960-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838331PMC
November 2019

More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine.

Chin Clin Oncol 2019 Oct;8(S1):S25

Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.09.03DOI Listing
October 2019

Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.

Leuk Res 2019 12 28;87:106230. Epub 2019 Sep 28.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106230DOI Listing
December 2019

Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia.

Br J Haematol 2019 10 22;187(2):e45-e48. Epub 2019 Aug 22.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786919PMC
October 2019

Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia.

Blood 2019 10;134(15):1257-1268

Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019002457DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788006PMC
October 2019

The feasibility of venetoclax and decitabine in therapy-related acute myeloid leukemia with concurrent advanced non-hematological malignancies.

Leuk Res 2019 09 30;84:106196. Epub 2019 Jul 30.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01452126193014
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2019.106196DOI Listing
September 2019

Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia.

Leukemia 2020 01 23;34(1):75-86. Epub 2019 Jul 23.

Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope Medical Center and Beckman Research Institute, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0522-9DOI Listing
January 2020

PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD acute myeloid leukemia.

Blood 2019 08 19;134(6):548-560. Epub 2019 Jun 19.

Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019001282DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688430PMC
August 2019

Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.

Methods Mol Biol 2019 ;1974:141-150

Department of Immuno-Oncology, Beckman Research Institute at City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-9220-1_10DOI Listing
November 2019

Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemia.

Bone Marrow Transplant 2020 02 14;55(2):473-475. Epub 2019 May 14.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0553-xDOI Listing
February 2020

Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.

J Cell Physiol 2019 08 22;234(10):17612-17621. Epub 2019 Feb 22.

Department of Medical Biotechnology, Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.28385DOI Listing
August 2019

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.

Br J Clin Pharmacol 2019 05 27;85(5):924-934. Epub 2019 Feb 27.

Australian Centre for Pharmacometrics, School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475687PMC
May 2019

The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML.

J Cell Physiol 2019 08 8;234(8):14040-14049. Epub 2019 Jan 8.

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.28091DOI Listing
August 2019

Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for use.

Am J Hematol 2019 03 13;94(3):358-362. Epub 2018 Dec 13.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25369
Publisher Site
http://dx.doi.org/10.1002/ajh.25369DOI Listing
March 2019

SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.

Cell Stem Cell 2018 09 23;23(3):355-369.e9. Epub 2018 Aug 23.

Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2018.07.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143172PMC
September 2018

The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implications.

Blood Rev 2019 01 14;33:98-105. Epub 2018 Aug 14.

University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2018.08.002DOI Listing
January 2019

The role of ErbB3 binding protein 1 in cancer: Friend or foe?

J Cell Physiol 2018 12 4;233(12):9110-9120. Epub 2018 Aug 4.

Department of Medical Biotechnology, Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.26951DOI Listing
December 2018

Aging in a Relativistic Biological Space-Time.

Front Cell Dev Biol 2018 29;6:55. Epub 2018 May 29.

Division of Mathematical Oncology, City of Hope, National Medical Center, Duarte, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fcell.2018.00055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986934PMC
May 2018

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/mA/MYC/CEBPA Signaling.

Cell 2018 01 14;172(1-2):90-105.e23. Epub 2017 Dec 14.

Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45219, USA; Gehr Family Center for Leukemia Research, City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2017.11.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766423PMC
January 2018

HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity.

Blood 2017 12 30;130(24):2619-2630. Epub 2017 Oct 30.

Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-03-771386DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731083PMC
December 2017

Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia.

Leuk Res 2017 08 10;59:124-135. Epub 2017 May 10.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA 91010, USA; Gehr Family Center for Leukemia Research City of Hope Medical Center, Duarte, CA 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.05.007DOI Listing
August 2017

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

N Engl J Med 2017 08 23;377(5):454-464. Epub 2017 Jun 23.

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston (R.M.S.); the Division of Biomedical Statistics and Informatics (S.J.M., K.L.) and the Alliance Statistics and Data Center (S.J.M., K.L., S.G.), Mayo Clinic, Rochester, MN; the Alliance Statistics and Data Center, Duke University, Durham, NC (B.L.S.); the Ohio State University Comprehensive Cancer Center, Columbus (S.G., C.D.B., T.W.P., G.M., R.B.K.); Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden (C.T., G.E.), Department of Internal Medicine III, University Hospital of Ulm, Ulm (K.D., R.F.S., H.D.), Hematology and Oncology, University of Leipzig, Leipzig (D.N.), Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover (J.K., A.G.), and Department of Medicine II, Hematology-Oncology, Goethe University Hospital Frankfurt, Frankfurt am Main (H.S.) - all in Germany; the Department of Biomedicine and Prevention, University Tor Vergata, Rome (F.L.-C., S.A.); the Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, VIC, Australia (A.W.); Hospital de la Santa Creu i Sant Pau, Hematology Department, Autonomous University of Barcelona, Barcelona (J.S.), and Hospital Universitario la Fe, Hematology Department, Department of Medicine, University of Valencia, Valencia (M.A.S.) - both in Spain; the Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto (J.M.B.); Radboud Institute Molecular Studies, Radboud University Medical Center, Nijmegen, the Netherlands (T.W.); the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (F.R.A.); the Division of Hematology-Oncology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA (B.C.M.); the Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (M.S.T.); and the Department of Medicine, University of Chicago, Chicago (R.A.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1614359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754190PMC
August 2017

Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia.

Am J Hematol 2017 Sep 5;92(9):858-865. Epub 2017 Jun 5.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24783DOI Listing
September 2017

Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children.

Oncology (Williston Park) 2016 12;30(12):1080-91

View Article

Download full-text PDF

Source
December 2016

Identification of a CD133-CD55- population functions as a fetal common skeletal progenitor.

Sci Rep 2016 12 8;6:38632. Epub 2016 Dec 8.

Divison of Hematopoietic Stem Cell and Leukemia Research, Gehr Family Center for Leukemia Research, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep38632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144148PMC
December 2016

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

J Clin Oncol 2017 Feb 21;35(4):394-401. Epub 2016 Nov 21.

Kathryn G. Roberts, Zhaohui Gu, Debbie Payne-Turner, Kelly McCastlain, Deqing Pei, Ilaria Iacobucci, Marcus Valentine, Stanley B. Pounds, Lei Shi, Yongjin Li, Jinghui Zhang, Cheng Cheng, and Charles G. Mullighan, St Jude Children's Research Hospital, Memphis, TN; Richard C. Harvey, I-Ming Chen, and Cheryl L. Willman, University of New Mexico Cancer Center, Albuquerque, NM; Alessandro Rambaldi, Manuela Tosi, and Orietta Spinelli, Ospedale Papa Giovanni XXIII, Bergamo, Italy; Jerald P. Radich, Fred Hutchinson Cancer Research Center, Seattle, WA; Mark D. Minden, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Jacob M. Rowe, Shaare Zedek Medical Center, Jerusalem, Israel; Selina Luger, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Mark R. Litzow, Mayo Clinic, Rochester, MN; Martin S. Tallman, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York; Peter H. Wiernik, Cancer Research Foundation of New York; Elisabeth Paietta, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Ravi Bhatia, The University of Alabama at Birmingham, Birmingham, AL; Ibrahim Aldoss and Guido Marcucci, City of Hope, Duarte, CA; Jessica Kohlschmidt, Krzysztof Mrózek, and Clara D. Bloomfield, Comprehensive Cancer Center, The Ohio State University, Columbus, OH; Wendy Stock, University of Chicago Medical Center, Chicago, IL; and Stephen Kornblau, Hagop M. Kantarjian, and Marina Konopleva, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455698PMC
February 2017

Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.

Am J Hematol 2017 Feb;92(2):E18-E19

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24604DOI Listing
February 2017

CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.

Oncotarget 2016 Nov;7(45):73558-73572

Division of Hematopoietic Stem Cell and Leukemia Research, Gehr Leukemia Center, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12434DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341999PMC
November 2016

CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice.

Blood 2016 09 21;128(11):1503-15. Epub 2016 Jul 21.

Division of Hematopoietic Stem Cell and Leukemia Research, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025900PMC
http://dx.doi.org/10.1182/blood-2016-01-693119DOI Listing
September 2016

Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Cancer Discov 2016 09 15;6(9):986-1005. Epub 2016 Jul 15.

Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio. Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-1297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388135PMC
September 2016

Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic Insights.

Oncology (Williston Park) 2016 Apr;30(4):318-29

View Article

Download full-text PDF

Source
April 2016

Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2016 07 1;22(7):1212-1217. Epub 2016 Apr 1.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.025DOI Listing
July 2016